对于患有注意缺陷多动障碍的儿童和青少年，哌醋甲酯的益处和危害仍存在争议。
The Jury Is Still Out on the Benefits and Harms of Methylphenidate for Children and Adolescents With Attention-Deficit/Hyperactivity Disorder.
机构信息
Psychiatric Research Unit, Region Zealand Psychiatry, Slagelse, Denmark.
Department of Psychology, University of Southern Denmark, Odense, Denmark.
出版信息
Clin Pharmacol Ther. 2018 Oct;104(4):606-609. doi: 10.1002/cpt.1149. Epub 2018 Jul 13.
DOI:10.1002/cpt.1149
PMID:30006934
Abstract
Much remains unclear about the benefits and harms of methylphenidate for children and adolescents with attention-deficit/hyperactivity disorder (ADHD). Between 2012 and 2018, we conducted two Cochrane systematic reviews on methylphenidate for ADHD. This article explores the main findings in relation to evidence-based practice and our current understanding of ADHD.
摘要
关于哌醋甲酯治疗儿童和青少年注意缺陷多动障碍（ADHD）的益处和危害，仍有许多不清楚的地方。在 2012 年至 2018 年期间，我们对哌醋甲酯治疗 ADHD 进行了两项 Cochrane 系统评价。本文探讨了与循证实践相关的主要发现以及我们目前对 ADHD 的理解。
Zotero 插件